EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.52) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $11.56 million which beat the analyst consensus estimate of $10.87 million by 6.39 percent. This is a 28.31 percent increase over sales of $9.01 million the same period last year.
S&P 500 Settles Lower Following Labor Report; Market Volatility Increases
The S&P 500 closed lower on Wednesday as investors assessed unexpectedly strong labor market report.
The Labor Department said the number of job vacancies in the U.S. rose by 358 thousand to 10.1 million in April. Traders are now seeing a 70% chance that the Fed will raise rates by 25 basis points at its June 13-14 policy meeting.
